Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and...
Single-use manufacturing solutions cover technical, operational, economic and strategic considerations for single-use technology and implementation.
Over the years such technologies have evolved to become a mainstream approach for achieving productivity. From single-use bioreactors and disposable chromatography columns to complete single-use workflows and biomanufacturing facilities, GE Healthcare Life Sciences has been at the forefront of single-use innovation. This transformation has been and will continue to be driven by collaboration with biomanufacturers and other industry experts.
A strategy for success
Adding a piece of single-use equipment is a step in the right direction of achieving higher productivity. But successful implementation of a widespread single-use biomanufacturing strategy requires a comprehensive approach. Based on GE’s decades of experience in biomanufacturing, a successful strategy encompasses these four pillars:
- Technical – develop scientific knowledge and experience
- Operational – secure and streamline implementation
- Economic – understand initial and on-going financial impact
- Strategic – develop flexible solutions with collaboration
Leverage the latest know-how
Single-use technologies offer opportunities to develop robust biomanufacturing processes quickly. Achieving this goal requires knowledge of materials, equipment, and consumables, as well as processes and how they work together. Process intensification applies this knowledge to reduce costs and improve process yields. Working with experienced technical experts can help the manufacturer achieve these goals the first time.
Single-use technology is more cost-effective than traditional stainless-steel methods in some situations. But economics is only one factor. Considering key variables, like time to market and required output, will help guide the client’s decision about which technology makes sense for their specific business objective.
Click here to see ‘Five Key Considerations for Successfully Creating cGMP Single-Use Biomanufacturing Capacity’ video.
Akeso Pharmaceuticals, a biotech company that focuses in the growth and commercialisation of innovative biologics,...
GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin,...
When you partner with GE Healthcare’s Life Sciences you get access to a wide selection...